SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IFLO is Breaking Out
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sergio H who wrote (894)3/27/2000 11:24:00 AM
From: James Strauss  Read Replies (1) of 1018
 
Sergio:

Here is something I posted on the Yahoo boards:

{{{If we just used a very conservative $35.00 average profit for both Painbuster and On-Q, and we estimate only 10% market penetration of the estimated 39 million surgeries done in the U.S. each year, we get $35.00 x 3,900,000 = $136,500,000 in profit alone... That divided by about 14 million shares = $9.75 eps on just Painbuster and On-Q alone with just 10% market penetration in the U.S... Add the other products and international sales, and you have a potential stock price over $100.00 a share with a relatively low P/E around 10... Imagine what happens when IFLO starts using the internet to augment its marketing...

I think we have a tiger by the tail... : > }}}

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News